The announcement that inhaled insulin will soon be available in India has understandably generated a lot of excitement and ...

Diabetes, a chronic condition that affects millions of people, may have a connection with Alzheimer's disease. Unofficially ...

Inhaled insulin was noninferior to usual care in glycemic control outcomes after 17 weeks among patients with type 1 diabetes.

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income ...

A law signed in 2023 caps out-of-pocket costs for insulin, asthma inhalers, and epinephrine injectors beginning Jan. 1.

Aerami Therapeutics (Aerami), formerly Aerami Therapeutics Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company provides a product pipeline ...

The product has been studied in a small group of patients with type 2 diabetes mellitus. [20] This study showed that the relative bioavailability of inhaled Aerodose insulin was approximately 21%.

In addition, they looked at how inhaled Technosphere insulin plus insulin degludec impacts people with type 1 diabetes using multiple daily insulin injections and a continuous glucose monitor. People ...